AlzBiomarker
Alzheimer's Disease vs Control: Aβ40 (CSF)
Meta-analysis Results: Studies using multiple methods have found a negligible difference in levels of Aβ40 in the cerebrospinal fluid of Alzheimer’s disease patients and controls (effect size= 0.928, p = 0.00056).

